Skip to main content
. 2022 Apr 4;10:835793. doi: 10.3389/fcell.2022.835793

FIGURE 4.

FIGURE 4

Disease free survival at 10 years: recipients ex-vivo expanded cells 86% (95% CI: 56–96) (Figure 4A). Cumulative incidence relapse (Figure 4B).